Pediatric Vaccines Market Research Report - Global Forecast till 2027

Pediatric Vaccines Market Research Report: Information by Type (Monovalent Vaccines and Multivalent Vaccines), Technology (Live Attenuated, Inactivated, Subunits, Toxoids, Conjugates and others), Application (Polio, Diphtheria-Tetanus-Acellular Pertussis, Haemophilus Influenzae type B, MMR, Hepatitis B, Pneumococcal Vaccine and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast till 2027

ID: MRFR/Pharma/4323-HCR | February 2021 | Region: Global | 95 pages

Please note that the assessment period of the report has been updated from 2019-2025 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Pediatric Vaccines Market is expected to register 10.4% CAGR during the forecast period of 2019 to 2025 and held a market value of USD 25.68 billion in 2018.


The vaccines administered to prevent children from contracting several non-infectious and infectious diseases are known as pediatric vaccines. These vaccines are heat-killed or inactivated viruses that lose their pathogenicity, i.e., the ability to cause a disease. Moreover, these inactivated antigens can stimulate the immune system to produce antibodies against the infected virus. Thus, they assist the immune system in protecting itself from infectious or non-infectious diseases in the future. Currently, immunization prevents an estimated 2-3 million deaths every year.


The global pediatric vaccines market is driven by factors such as global initiative undertaken by key players in developing innovative vaccines and increasing government support. Additionally, increasing awareness regarding the benefits of vaccination in prevention of diseases is anticipated to fuel market growth. For instance, in June 2016, Inovio Pharmaceuticals, Inc. stated the commencement of phase I clinical trial for their Zika DNA vaccine named GLS-570. Similarly, in December 2018, Sanofi S.A. received FDA approvals for its Vaxelis vaccine. On the other hand, the increasing availability of biosimilars at low rates and increasing cost of vaccines are projected to hamper the growth of the market during the assessment period.


Moreover, major companies in the market are involved in strategic acquisitions, product launch, collaborations, expansion, and mergers to sustain their position in the market.


Segmentation


The Global Pediatric Vaccines Market has been segmented based on type, technology, application, and region.


The global pediatric vaccines market, based on type, has been divided into monovalent vaccines and multivalent vaccines.


The global pediatric vaccines market, based on technology, has been segmented into live attenuated, inactivated, subunits, toxoids, conjugates, and others. The live attenuated segment is expected to hold a major share in the market due to the wide range of its application.


The global pediatric vaccines market, based on application, has been segmented into polio, diphtheria-tetanus-acellular pertussis (DTaP), Haemophilus influenzae type B (Hib), MMR (Mumps, Measles, and Rubella), Hepatitis B, pneumococcal vaccine, and others.


The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The pediatric vaccines market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European pediatric vaccines market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The pediatric vaccines market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The pediatric vaccines market in the Middle East & Africa has been divided into the Middle East and Africa.


Key Players


The Key Players operating in the Global Pediatric Vaccines Market are Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Grifols, Serum Institute of India Pvt. Ltd., AstraZeneca, Cadila Healthcare Ltd, Indian Immunologicals Limited, and CSL Limited.


Regional Market Summary


Global Pediatric Vaccines Market Share, by Region, 2018 (%)  Pediatric Vaccines Market


Source: World Health Organization (WHO)


The pediatric vaccines market in the Americas is expected to dominate the global pediatric vaccines market due to the presence of major established players in the region and increasing R&D expenses.


Europe is expected to hold the second-largest position in the global pediatric vaccines market. This can be attributed to the presence of a well-established healthcare system and an increase in infectious diseases.


Asia-Pacific is expected to be the fastest-growing region owing to the growing population and increasing awareness about the vaccine’s products.


The pediatric vaccines market in the Middle East & Africa is projected to account for the least share of the market due to the low per capita disposable income in the region.


Global Pediatric Vaccines Market, by Type



  • Monovalent Vaccines

  • Multivalent Vaccines


Global Pediatric Vaccines Market, by Technology



  • Live Attenuated

  • Inactivated

  • Subunits

  • Toxoids

  • Conjugates

  • Others


Global Pediatric Vaccines Market, by Application



  • Polio

  • Diphtheria-Tetanus-Acellular Pertussis (DTaP)

  • Haemophilus Influenzae Type B (Hib)

  • MMR (Mumps, Measles, and Rubella)

  • Hepatitis B

  • Pneumococcal Vaccine

  • Others


Global Pediatric Vaccines Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Research and development (R&D) companies

  • Pediatric Vaccines manufacturing companies

  • Government research institutes

  • Academic institutes and universities

  • Venture capitalists



Report Scope:
Report Attribute/Metric Details
  Market Size   2025: Significant Value
  CAGR   10.4% (2019-2025)
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Technology, Application
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Grifols, Serum Institute of India Pvt. Ltd., AstraZeneca, Cadila Healthcare Ltd, Indian Immunologicals Limited, and CSL Limited.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers   Increasing awareness regarding the benefits of vaccination in prevention of diseases is anticipated to fuel market growth


Frequently Asked Questions (FAQ) :


Pediatric Vaccines Market is projected to grow at a 10.4 % CAGR between 2020-2027.

The Americas is expected to lead the Pediatric Vaccines Market.

It is widely used for hepatitis B, polio, MMR, and others.

Key players in the Pediatric Vaccines Market include CSL Limited, Indian Immunologicals Limited, Cadila Healthcare Ltd, AstraZeneca, Serum Institute of India Pvt. Ltd., Grifols, Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, and Sanofi S.A.

Different strategies used by market players to create a dominance in the Pediatric Vaccines Market include product launch, strategic alliances, mergers, and expansions.

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL VEIN ILLUMINATOR MARKET, BY TYPE

6.1. Overview

6.2. Monovalent Vaccines

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3. Multivalent Vaccines

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7. GLOBAL VEIN ILLUMINATOR MARKET, BY TECHNOLOGY

7.1. Overview

7.2. Live Attenuated

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3. Inactivated

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4. Subunits

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5. Toxoids

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6. Conjugates

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.7. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8. GLOBAL VEIN ILLUMINATOR MARKET, BY APPLICATION

8.1. Overview

8.2. Polio

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3. Diphtheria-Tetanus-Acellular Pertussis (DTaP)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4. Haemophilus Influenzae Type B (Hib)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5. MMR (Mumps, Measles, and Rubella)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.6. Hepatitis B

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.7. Pneumococcal Vaccine

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.8. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9. GLOBAL VEIN ILLUMINATOR MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1.1. Overview

10.1.2. Competitive Analysis

11. COMPANY PROFILE

11.1. Sanofi S.A.

11.1.1. Overview

11.1.2. Product Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. GlaxoSmithKline plc

11.2.1. Overview

11.2.2. Product Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Merck & Co., Inc.

11.3.1. Overview

11.3.2. Product Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Pfizer Inc.

11.4.1. Overview

11.4.2. Product Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Grifols

11.5.1. Overview

11.5.2. Product Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Serum Institute of India Pvt. Ltd

11.6.1. Overview

11.6.2. Product Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. AstraZeneca

11.7.1. Overview

11.7.2. Product Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Cadila Healthcare Ltd

11.8.1. Overview

11.8.2. Product Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Indian Immunologicals Limited

11.9.1. Overview

11.9.2. Product Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. CSL Limited

11.10.1. Overview

11.10.2. Product Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Others

12. APPENDIX

12.1. References

12.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL VEIN ILLUMINATOR MARKET SYNOPSIS, 2020–2027

TABLE 2 GLOBAL VEIN ILLUMINATOR MARKET ESTIMATES AND FORECAST, 2020–2027 (USD MILLION)

TABLE 3 GLOBAL VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 4 GLOBAL VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 5 GLOBAL VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 6 GLOBAL VEIN ILLUMINATOR MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 7 NORTH AMERICA: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 8 NORTH AMERICA: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 9 NORTH AMERICA: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 10 US: VEIN ILLUMINATOR MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 11 US: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 12 US: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 13 CANADA: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 14 CANADA: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 15 CANADA: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 16 LATIN AMERICA: VEIN ILLUMINATOR MARKET, BY DRUG CLASS, 2020–2027 (USD MILLION)

TABLE 17 LATIN AMERICA: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 18 LATIN AMERICA: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 19 EUROPE: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 20 EUROPE: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 21 EUROPE: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 22 WESTERN EUROPE: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 23 WESTERN EUROPE: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 24 WESTERN EUROPE: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 25 EASTERN EUROPE: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 26 EASTERN EUROPE: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 27 EASTERN EUROPE: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: VEIN ILLUMINATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: VEIN ILLUMINATOR MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: VEIN ILLUMINATOR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE OF THE GLOBAL VEIN ILLUMINATOR MARKET

FIGURE 3 MARKET DYNAMICS OF THE GLOBAL VEIN ILLUMINATOR MARKET

FIGURE 4 GLOBAL VEIN ILLUMINATOR MARKET SHARE, BY TYPE, 2020 (%)

FIGURE 5 GLOBAL VEIN ILLUMINATOR MARKET SHARE, BY TECHNOLOGY, 2020 (%)

FIGURE 6 GLOBAL VEIN ILLUMINATOR MARKET SHARE, BY APPLICATION, 2020 (%)

FIGURE 7 GLOBAL VEIN ILLUMINATOR MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 NORTH AMERICA: VEIN ILLUMINATOR MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 9 EUROPE: VEIN ILLUMINATOR MARKET SHARE, BY REGION, 2020 (%)

FIGURE 10 WESTERN EUROPE: VEIN ILLUMINATOR MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 ASIA-PACIFIC: VEIN ILLUMINATOR MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 MIDDLE EAST & AFRICA: VEIN ILLUMINATOR MARKET SHARE, BY REGION, 2020 (%)

FIGURE 13 GLOBAL VEIN ILLUMINATOR MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 14 SANOFI S.A.: KEY FINANCIALS

FIGURE 15 SANOFI S.A.: SEGMENTAL REVENUE

FIGURE 16 SANOFI S.A.: REGIONAL REVENUE

FIGURE 17 GLAXOSMITHKLINE PLC: KEY FINANCIALS

FIGURE 18 GLAXOSMITHKLINE PLC: SEGMENTAL REVENUE

FIGURE 19 GLAXOSMITHKLINE PLC: REGIONAL REVENUE

FIGURE 20 MERCK & CO., INC.: KEY FINANCIALS

FIGURE 21 MERCK & CO., INC.: SEGMENTAL REVENUE

FIGURE 22 MERCK & CO., INC.: REGIONAL REVENUE

FIGURE 23 PFIZER INC.: KEY FINANCIALS

FIGURE 24 PFIZER INC.: SEGMENTAL REVENUE

FIGURE 25 PFIZER INC.: REGIONAL REVENUE

FIGURE 26 GRIFOLS: KEY FINANCIALS

FIGURE 27 GRIFOLS: SEGMENTAL REVENUE

FIGURE 28 GRIFOLS: REGIONAL REVENUE

FIGURE 29 SERUM INSTITUTE OF INDIA PVT. LTD: KEY FINANCIALS

FIGURE 30 SERUM INSTITUTE OF INDIA PVT. LTD: SEGMENTAL REVENUE

FIGURE 31 SERUM INSTITUTE OF INDIA PVT. LTD: REGIONAL REVENUE

FIGURE 32 ASTRAZENECA: KEY FINANCIALS

FIGURE 33 ASTRAZENECA: SEGMENTAL REVENUE

FIGURE 34 ASTRAZENECA: REGIONAL REVENUE

FIGURE 35 CADILA HEALTHCARE LTD: KEY FINANCIALS

FIGURE 36 CADILA HEALTHCARE LTD: SEGMENTAL REVENUE

FIGURE 37 CADILA HEALTHCARE LTD: REGIONAL REVENUE

FIGURE 38 INDIAN IMMUNOLOGICALS LIMITED: KEY FINANCIALS

FIGURE 39 INDIAN IMMUNOLOGICALS LIMITED: SEGMENTAL REVENUE

FIGURE 40 INDIAN IMMUNOLOGICALS LIMITED: REGIONAL REVENUE

FIGURE 41 CSL LIMITED: KEY FINANCIALS

FIGURE 42 CSL LIMITED: SEGMENTAL REVENUE

FIGURE 43 CSL LIMITED: REGIONAL REVENUE